Johnson & Johnson
Generated by GPT-5-miniExpansion Funnel Raw 88 → Dedup 37 → NER 37 → Enqueued 15
| Johnson & Johnson | |
|---|---|
| Name | Johnson & Johnson |
| Type | Public |
| Founded | 1886 |
| Founders | Robert Wood Johnson I, James Wood Johnson, Edward Mead Johnson |
| Headquarters | New Brunswick, New Jersey, United States |
| Key people | Joaquin Duato, Albert J. Rizzo, William C. Weldon |
| Industry | Pharmaceuticals, Medical devices, Consumer health |
| Revenue | US$ (2025 est.) |
| Employees | 140,000+ |
Johnson & Johnson Johnson & Johnson is an American multinational corporation founded in 1886 and headquartered in New Brunswick, New Jersey. The company operates across United States, Europe, Asia, and Latin America with business segments spanning pharmaceuticals, medical devices, and consumer health products. Its brands and operations have interacted with institutions such as Food and Drug Administration, World Health Organization, University of Pennsylvania, and regulatory regimes in jurisdictions including European Union, United Kingdom, and China. Over its history the company has been involved with major events and figures in medicine and public health, including collaborations with Centers for Disease Control and Prevention, partnerships with Bill & Melinda Gates Foundation, and litigation involving courts like the Supreme Court of the United States.
History
The company was founded by brothers Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson in 1886 in New Brunswick, New Jersey to produce sterile surgical dressings and other medical supplies. Early growth involved ties to hospitals such as Presbyterian Hospital (New York City) and innovations used by clinicians at institutions like Johns Hopkins Hospital. In the 20th century the firm expanded through acquisitions and product launches, interacting with pharmaceutical milestones at Merck & Co., Pfizer, and Eli Lilly and Company. During both World Wars the company supplied medical products to forces including the United States Army and Allied medical services, and postwar expansions saw manufacturing in regions such as Puerto Rico and Belgium.
Leadership transitions included figures like Edward Mead Johnson leaving to form Mead Johnson, and later executives such as William C. Weldon and Alex Gorsky guiding globalization into markets like India and Brazil. The company’s corporate actions have intersected with financial institutions including the New York Stock Exchange and legal institutions like the United States District Court for the District of New Jersey.
Products and divisions
The corporation’s business is structured into major divisions: pharmaceuticals, medical devices, and consumer health. Pharmaceutical products include oncology, immunology, and cardiovascular drugs developed and marketed alongside companies such as Novartis, Roche, and GlaxoSmithKline. Medical devices encompass orthopedics, surgery, and cardiovascular products competing with Medtronic, Stryker Corporation, and Boston Scientific. Consumer health brands include over-the-counter products and baby care items sold globally and recognized alongside brands from Procter & Gamble, Unilever, and Colgate-Palmolive.
Flagship consumer brands and product lines have been distributed through retail partners like Walmart, CVS Health, and Walgreens Boots Alliance and have been used in healthcare settings at institutions including Mayo Clinic and Cleveland Clinic. The company’s portfolio has been reshaped by divestitures and purchases, engaging with corporations such as AbbVie, Actelion, and Bausch Health Companies.
Research and development
R&D activities occur at research centers and collaborations with universities and biotech firms such as Massachusetts Institute of Technology, Harvard Medical School, Stanford University, University of Cambridge, University of Oxford, and startups funded through partnerships with Johnson & Johnson Innovation and venture capital firms. The company has participated in vaccine development efforts in coordination with agencies like Operation Warp Speed and international partners including Gavi, the Vaccine Alliance.
Clinical trials have been registered with regulators and run at academic medical centers such as Mount Sinai Health System and UCLA Health, and have involved investigational therapeutics alongside collaborators like Bayer and Amgen. The company’s R&D strategy spans small molecules, biologics, and medical devices, and has leveraged acquisitions of biotech firms including Actelion and collaborations with companies like Janssen Biotech to augment pipelines.
Legal issues and controversies
The company has faced litigation and controversies in areas including product liability, regulatory compliance, and marketing practices. High-profile legal matters have been adjudicated in courts including the Supreme Court of the United States and federal district courts, involving plaintiffs represented by law firms and regulators such as the Department of Justice (United States). Cases have concerned talc-based products, opioid-related claims alongside other manufacturers like Purdue Pharma, and recalls overseen by the Food and Drug Administration.
Settlements and verdicts have implicated corporate governance debates involving boards and shareholders, and have overlapped with investigative reporting by media outlets such as The New York Times and The Wall Street Journal. The company’s legal responses have included appeals to appellate courts like the United States Court of Appeals for the Third Circuit and negotiations with state attorneys general from jurisdictions such as New York (state) and California.
Corporate governance and financials
Corporate governance is overseen by a board of directors that has included executives and independent directors with experience at institutions like Goldman Sachs, Morgan Stanley, General Electric, and Boeing. Chief executive officers and senior management have engaged with investors at forums such as the New York Stock Exchange and annual meetings attended by proxy advisory firms like Institutional Shareholder Services.
Financial reporting is conducted under accounting standards enforced by the Securities and Exchange Commission and audited by major accounting firms. The company’s stock is included in indices such as the Dow Jones Industrial Average and S&P 500, and its financial performance has been compared with peers including Johnson Controls International and Bristol-Myers Squibb in analyst coverage by firms like JPMorgan Chase and Goldman Sachs.
Corporate social responsibility and philanthropy
Philanthropic initiatives have involved partnerships with foundations and NGOs including the Bill & Melinda Gates Foundation, UNICEF, and American Red Cross. Corporate social responsibility programs have targeted public health challenges and disaster relief in collaboration with agencies such as World Health Organization and academic partners like Columbia University.
Sustainability reporting aligns with frameworks from organizations such as Global Reporting Initiative and the United Nations Global Compact, and initiatives have included commitments to environmental targets and workplace diversity programs benchmarked against standards from Catalyst and Human Rights Campaign.